Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Hormone-dependent prostate cancer: Which Medications Are Safest? (42 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

42 medications are used for Hormone-dependent prostate cancer, with 1,731 combined adverse event reports. The most reported drugs for Hormone-dependent prostate cancer are APALUTAMIDE and DAROLUTAMIDE.

1,731
Total Reports
42
Drugs Used

All Medications for Hormone-dependent prostate cancer Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
APALUTAMIDE ERLEADA 533 1,286 2,136 13.5%
DAROLUTAMIDE NUBEQA 294 508 723 15.6%
ENZALUTAMIDE Xtandi 289 9,676 9,282 19.6%
ABIRATERONE Abiraterone Acetate 236 7,180 8,816 20.8%
DEGARELIX FIRMAGON 187 484 1,333 12.8%
LEUPROLIDE Fensolvi 181 11,858 10,499 16.7%
DOCETAXEL Docetaxel 90 6,068 13,463 9.3%
PREDNISONE prednisone 47 22,555 57,772 14.2%
DOCETAXEL\DOCETAXEL ANHYDROUS - 42 499 1,438 13.0%
GALLIUM GA-OZETOTIDE Gallium Ga-68 PSMA-11 41 4 35 2.0%
ZOLEDRONIC ACID Zoledronic acid 35 5,240 8,346 15.6%
BICALUTAMIDE Bicalutamide 32 462 1,486 11.4%
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN PLUVICTO 32 1,461 545 13.6%
PREDNISOLONE Prednisolone Sodium Phosphate 27 13,159 32,883 16.3%
ABEMACICLIB Verzenio 24 1,243 3,635 7.6%
PEMBROLIZUMAB KEYTRUDA 19 15,543 35,472 18.6%
GOSERELIN ZOLADEX 13 1,535 1,546 24.1%
TRIPTORELIN TRIPTODUR 13 528 1,315 9.8%
PSMA-HBED-CC - 12 3 25 7.5%
RELUGOLIX Orgovyx 8 958 1,699 4.6%

View all 42 drugs →

Most Reported Drugs for Hormone-dependent prostate cancer

#1 most reported
#2 most reported
#3 most reported